Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues

Human Pathology

Volumn 28, Issue 4, 1997, Pages 459-464

  Corless, Christopher L ^a   Kibel, Adam S ^a   Iliopoulos, Othon ^a   Kaelin Jr , William G ^a  

^a Department of Pathology ^*

Author keywords

immunohistochemistry; kidney; pheochromocytoma; renal cell carcinoma; von Hippel Lindau disease

Indexed keywords

COMPLEMENTARY DNA; ELONGATION FACTOR; EPITOPE; GENE PRODUCT;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL PROTOCOL; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PHEOCHROMOCYTOMA; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0030948396     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90035-6     Document Type: Article

References (25)

1. Melmon KL, Rosen SW: Lindau's disease: Review of the literature and study of a large kindred. Am J Med 36:595-617, 1964
2. Horton WA, Wong V, Eldridge R: Von Hippel-Lindau disease: Clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 136:769-777, 1976
3. Gaffey MJ, Mills SE, Boyd JC: Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma: Manifestations of von Hippel-Lindau Disease. Am J Surg Pathol 18:1254-1260, 1994
4. Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993
5. Gnarra JR, Tory K, Weng Y, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90, 1994
6. Chen F, Kishida T, Yao M, et al: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mutat 5:66-75, 1995
7. Whaley JM, Naglich J, Gelbert L, et al: Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. AmJ Hum Genet 55:1092-1102, 1994
8. Shuin T, Kondo K, Torigoe S, et al: Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855, 1994
9. Foster K, Prowse A, van den Berg A, et al: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal cell carcinoma. Hum Mol Genet 3:2169-2173, 1994
10. Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847, 1994
11. Gilcrease MZ, Schmidt L, Zbar B, et al: Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. HUM PATHOL 26:1341-1346, 1995
12. Iliopoulos O, Kibel A, Gray S, et al: Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1:822-826, 1995
13. Duan DR, Pause A, Burgess WH, et al: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406, 1995
14. Kibel A, Iliopoulos O, DeCaprio JA, et al: Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269:1444-1446, 1995
15. Duan DR, Humphrey JS, Chen DYT, et al: Characterization of the VHL tumor suppressor gene product: Localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci 92:6459-6463, 1995
16. Lee S, Chen DYT, Humphrey JS, et al: Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci 93:1770-1775, 1996
17. Kessler PM, Vasavada SP, Rackley RR, et al: Expression of the von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis. Mol Med 1:457-466, 1995
18. Hinds PW: The retinoblastoma tumor suppressor protein. Curr Opin Genet Dev 5:79-83, 1995
19. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708, 1989
20. Cohen C, McCue PA, Derose PB: Histogenesis of renal cell carcinoma and renal oncocytoma: An immunohistochemical study. Cancer 62:1946-1951, 1988
21. Crossey PA, Richards FM, Foster K, et al: Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308, 1994
22. Kishida T, Stackhouse TM, Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544-4548, 1995
23. Herman JG, Latif F, Weng Y, et al: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci 91:9700-9704, 1994
24. Sekido Y, Bader S, Latif F, et al: Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9:1599-1604, 1994
25. Zhuang Z, Emmert-Buck MR, Roth MJ, et al: Von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. HUM PATHOL 27:152-156, 1996